In other countries
The same active substances on other registers, the same brand first.
- LucentisBrazil · Novartis Biociencias S.ASame brand
- LucentisCanada · 10 MG / ML · Solution · Novartis Pharmaceuticals Canada INCSame brand
- LucentisCanada · 10 MG / ML · Solution · Novartis Pharmaceuticals Canada INCSame brand
- LucentisEuropean Union · Novartis Europharm LimitedSame brand
- LucentisCroatiaSame brand
- LucentisItaly · Soluzione iniettabile · Novartis Europharm LimitedSame brand
- Lucentis 10 MG/MLNetherlands · Oplossing voor injectie · Novartis Europharm LimitedSame brand
- LUCENTIS 10mg/mlRomania · 10mg/ml · sol. inj. · Novartis Europharm LTD.Same brand
- LUCENTIS 10MG-ML INTRAVITREAL Injection*Saudi Arabia · NovartisSame brand
- LUCENTIS 10MG-ML INTRAVITREAL InjectionSaudi Arabia · NOVARTIS Pharma Stein AGSame brand
- Lucentis 10mg/ml Solution for InjectionSingapore · 2.3mg · injection, solution · Novartis (Singapore) Pte LTDSame brand
- LUCENTIS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 1.65mg/0.165mlSingapore · 1.65mg/0.165ml · injection, solution · Novartis (Singapore) Pte LTDSame brand
- LucentisUnited States · 10MG/ML · Injection · Genentech, Inc.Same brand
- LucentisUnited States · 10MG/ML, 6MG/ML · Injectable · GenentechSame brand
- LucentisUnited States · 6MG/ML · Injection · Genentech, Inc.Same brand
- ByoovizItaly · Soluzione iniettabile · Samsung Bioepis NL B.V.Same form
- EpruvyItaly · Soluzione iniettabile · Midas Pharma GMBHSame form
- Byooviz 10 mg/ml, oplossing voor injectieNetherlands · Oplossing voor injectie · Samsung Bioepis NL B.V.Same form
- Epruvy 10 mg/ml oplossing voor injectieNetherlands · Oplossing voor injectie · Midas Pharma GmbHSame form
- AnyNew Zealand · Inj 10 mg per ml, 0.23 ml vialSame form
- AnyNew Zealand · Inj 10 mg per ml, 0.3 ml vialSame form
- AmelivuBrazil · Samsung Bioepis br Pharmaceutical ltda.Same substance
- OptinóvisBrazil · Bionovis S.A. - Companhia Brasileira de Biotecnologia FarmaceuticaSame substance
- MelvizoCanada · 10 MG / ML · Solution · Samsung Bioepis Co., LTDSame substance
- ByoovizEuropean Union · Samsung Bioepis NL B.V.Same substance
- Epruvy (previously Ranibizumab Midas)European Union · Midas Pharma GmbHSame substance
- RimmyrahCroatiaSame substance
- XimluciCroatiaSame substance
Packs
| Pack | Code | Status |
|---|---|---|
| LUCENTIS 10 MG/ML SOLUCION INYECTABLE 1 vial de 0,23 ml + 1 aguja con filtro | 704876 |
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Ranibizumab
- Strength
- 2,3 mg
- Dosage form
- solución inyectable
- Route
- vía intravítrea
- Register
- Spain (AEMPS)
- Status
- Marketed
- Status in the register
- Autorizado, comercializado
- Authorised
- 14 Jan 2015
- Registration
- 106374004
- Marketing authorisation holder
- Novartis Europharm Limited
- Procedure
- EU centralised
- Supply
- Uso Hospitalario